| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.602 | 19.795 | 22.488 | 28.377 | 37.138 | 44.151 | 45.656 | 63.073 | 75.299 | 87.543 |
| Total Income - EUR | 1.602 | 19.795 | 22.489 | 28.377 | 37.138 | 44.182 | 45.657 | 63.074 | 75.299 | 87.543 |
| Total Expenses - EUR | 2.005 | 11.041 | 15.583 | 22.663 | 33.159 | 41.136 | 46.791 | 44.429 | 58.298 | 71.471 |
| Gross Profit/Loss - EUR | -403 | 8.754 | 6.906 | 5.715 | 3.979 | 3.046 | -1.135 | 18.645 | 17.000 | 16.072 |
| Net Profit/Loss - EUR | -451 | 8.556 | 6.661 | 5.431 | 3.608 | 2.604 | -1.592 | 18.014 | 16.247 | 12.882 |
| Employees | 1 | 2 | 3 | 3 | 4 | 4 | 4 | 2 | 2 | 2 |
Check the financial reports for the company - Rosamed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 1.686 | 1.846 | 29.193 | 31.064 | 41.944 | 36.760 | 32.282 | 28.991 |
| Current Assets | 803 | 1.800 | 2.518 | 9.433 | 8.778 | 12.538 | 9.702 | 37.547 | 43.332 | 63.023 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 464 | 0 |
| Receivables | 801 | 1.642 | 1.679 | 4.136 | 2.604 | 4.309 | 4.525 | 14.970 | 12.335 | 4.537 |
| Cash | 2 | 157 | 839 | 5.298 | 6.174 | 8.229 | 5.177 | 22.577 | 30.533 | 58.486 |
| Shareholders Funds | -13.956 | -5.258 | 1.416 | 6.821 | 10.297 | 12.706 | 10.833 | 28.880 | 45.040 | 55.182 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 14.759 | 7.057 | 2.788 | 4.458 | 27.674 | 30.896 | 41.207 | 45.427 | 30.574 | 36.832 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Rosamed Srl